Development and Psychometric Evaluation of an Instrument Assessing Barriers to Growth Hormone Treatment (BAR-GHT)

Conclusions: The final 19-item BAR-GHT for patients aged 8–18 years and the 16-item version for parents can be considered reliable and valid PROs of barriers to GHT.Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT03672617.Universal Trial Number (UTN) of the International Clinical Trials Registry Platform (ICTRP, www.who.int): U1111-1210-1036.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research